Your browser doesn't support javascript.
loading
Telmisartan induces a specific gut microbiota signature which may mediate its antiobesity effect.
Beckmann, Laura; Künstner, Axel; Freschi, Marco L; Huber, Gianna; Stölting, Ines; Ibrahim, Saleh M; Hirose, Misa; Freitag, Miriam; Langan, Ewan A; Matschl, Urte; Galuska, Christina E; Fuchs, Beate; Knobloch, Johannes K; Busch, Hauke; Raasch, Walter.
Afiliación
  • Beckmann L; Institute of Experimental and Clinical Pharmacology and Toxicology, University of Lübeck, Germany.
  • Künstner A; Medical Systems Biology Group, Institute of Experimental Dermatology, University of Lübeck, Germany; Institute for Cardiogenetic, University of Lübeck, Germany.
  • Freschi ML; Institute of Experimental and Clinical Pharmacology and Toxicology, University of Lübeck, Germany.
  • Huber G; Institute of Experimental and Clinical Pharmacology and Toxicology, University of Lübeck, Germany; DZHK (German Centre for Cardiovascular Research), Partner Site Hamburg/Kiel/Lübeck, Lübeck, Germany; CBBM (Center of Brain, Behavior and Metabolism), Germany.
  • Stölting I; Institute of Experimental and Clinical Pharmacology and Toxicology, University of Lübeck, Germany.
  • Ibrahim SM; Institute of Experimental Dermatology, University of Lübeck, Germany.
  • Hirose M; Institute of Experimental Dermatology, University of Lübeck, Germany.
  • Freitag M; Departement of Dermatology, University of Lübeck, Germany.
  • Langan EA; Departement of Dermatology, University of Lübeck, Germany; Dermatological Sciences, University of Manchester, UK.
  • Matschl U; Department Virus Immunology, Heinrich Pette Institute, Leibniz Institute for Experimental Virology, Hamburg, Germany.
  • Galuska CE; Leibniz Institute for Farm Animal Biology (FBN) Core Facility Metabolomics, Germany.
  • Fuchs B; Leibniz Institute for Farm Animal Biology (FBN) Core Facility Metabolomics, Germany.
  • Knobloch JK; Clinic of Infectiology and Microbiology, University Clinic Schleswig-Holstein, Campus Lübeck, Germany; DZHK (German Centre for Cardiovascular Research), Partner Site Hamburg/Kiel/Lübeck, Lübeck, Germany; Insitute for Medical Microbiology, Virology and Hygiene, University Medical Center Hamburg-Eppen
  • Busch H; Medical Systems Biology Group, Institute of Experimental Dermatology, University of Lübeck, Germany; Institute for Cardiogenetic, University of Lübeck, Germany.
  • Raasch W; Institute of Experimental and Clinical Pharmacology and Toxicology, University of Lübeck, Germany; DZHK (German Centre for Cardiovascular Research), Partner Site Hamburg/Kiel/Lübeck, Lübeck, Germany; CBBM (Center of Brain, Behavior and Metabolism), Germany. Electronic address: walter.raasch@uni-lueb
Pharmacol Res ; 170: 105724, 2021 08.
Article en En | MEDLINE | ID: mdl-34116209
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Bacterias / Aumento de Peso / Fármacos Antiobesidad / Bloqueadores del Receptor Tipo 1 de Angiotensina II / Microbioma Gastrointestinal / Telmisartán / Obesidad Tipo de estudio: Etiology_studies / Prognostic_studies Límite: Animals Idioma: En Revista: Pharmacol Res Asunto de la revista: FARMACOLOGIA Año: 2021 Tipo del documento: Article País de afiliación: Alemania
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Bacterias / Aumento de Peso / Fármacos Antiobesidad / Bloqueadores del Receptor Tipo 1 de Angiotensina II / Microbioma Gastrointestinal / Telmisartán / Obesidad Tipo de estudio: Etiology_studies / Prognostic_studies Límite: Animals Idioma: En Revista: Pharmacol Res Asunto de la revista: FARMACOLOGIA Año: 2021 Tipo del documento: Article País de afiliación: Alemania